Search
Compass Therapeutics Inc.
CMPXAdd to Watchlist
1.910USD
-0.030-1.55%
Close 07-31 16:00（ET）Quotes delayed by 15 min
343.97MMarket Cap
LossP/E TTM
Compass Therapeutics Inc.'s Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Compass Therapeutics Inc. is 6.43, ranking 301 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -4.78, which is -53.19% below the recent high of -2.24 and -224.01% above the recent low of -15.49.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.